Regulatory watch Last reviewed Jul 1, 2026 Next review Jul 29, 2026 Evidence snapshot AOD-9604 was developed by Metabolic Pharmaceuticals (Australia) as a modified C-terminal fragment (residues 177-191) of human growth hormone, designed to retain lipolytic activity without growth-promoting effects
Antiviral medications like acyclovir (400mg three times daily) can reduce outbreak duration by 1-2 days when started within 72 hours, while topical benzoyl peroxide or salicylic acid treats bacterial skin lesions
preliminary evidence exists only for osteoarthritis via intra-articular injection Quick Facts Overview & Origin AOD-9604 (Anti-Obesity Drug 9604) is a 16-amino acid peptide comprising the C-terminal fragment of human growth hormone (hGH), specifically residues 177-191 of the native hormone, with an additional tyrosine residue at the N-terminus
You'll learn about the potential benefits of these treatments, such as vitamin b12 weight loss injections, and important considerations before starting any new health regimen
It's also where the honesty has to come in
